Sponsor Pipeline

Michael Peluso, MD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05877508 Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) Long COVID Active, Not Recruiting
NCT07145164 Interleukin-15 to Promote Post-ART Control of HIV HIV Enrolling by Invitation
Get alerts when Michael Peluso, MD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free